Print Print    Close Close

Cancer Vaccine Could Be Available in 3 Years

Published October 26, 2015

The Sun
60a502c2-US FLU SHOT

A cancer vaccine could be ready in three years after promising trial results.

The vaccine trains immune systems to destroy tumors, and worked in 90 percent of breast cancer cases in lab tests

It forces antibodies to zoom in on the coating that surrounds cancers and kills them off. In tests on mice, it was particularly successful on breast and pancreatic tumors.

A team from the University of Georgia developed the vaccine and medics are now beginning tests on human cells.

Clinical trials could begin on humans by 2013. Study leader Professor Geert-Jan Boons said, "The vaccine elicits a very strong immune response. It activates all three components of the immune system to reduce tumor size."

[pullquote]

Co-author Professor Sandra Gendler, of the Mayo Clinic in Arizona, added, "This is the first time a vaccine has been developed that trains the immune system to distinguish and kill cancer cells based on their different sugar structures."

British experts welcomed the findings. Dr Caitlin Palframan, of Breakthrough Breast Cancer, said: "This exciting new approach could lead to treatments for breast cancer patients who have few options."

But she said trials on patients are needed.

Click here to read more from The Sun.

Print Print    Close Close

URL

https://www.foxnews.com/health/cancer-vaccine-could-be-available-in-3-years

  • Home
  • Video
  • Politics
  • U.S.
  • Opinion
  • Entertainment
  • Tech
  • Science
  • Health
  • Travel
  • Lifestyle
  • World
  • Sports
  • Weather
  • Privacy
  • Terms

This material may not be published, broadcast, rewritten, or redistributed. © FOX News Network, LLC. All rights reserved. Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. Mutual Fund and ETF data provided by LSEG. Do Not Sell my Personal Information - New Terms of Use - FAQ